121 related articles for article (PubMed ID: 4987349)
21. The inhibition of xanthine oxidase activity by benzodiarone.
Marcolongo R; Marinello E; Riario-Sforza G; Pagani R
Clin Chim Acta; 1972 Oct; 41():91-4. PubMed ID: 4645254
[No Abstract] [Full Text] [Related]
22. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
23. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
Rapado Errazti A
Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):304-6. PubMed ID: 5997999
[No Abstract] [Full Text] [Related]
24. [A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
Bossini A; De Martino Rosaroll G
Policlinico Prat; 1969 Jul; 76(30):961-73. PubMed ID: 5402682
[No Abstract] [Full Text] [Related]
25. Effect of allopurinol on iron mobilization.
Grace ND; Greenwald MA; Greenberg MS
Gastroenterology; 1970 Jul; 59(1):103-8. PubMed ID: 5426980
[No Abstract] [Full Text] [Related]
26. Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Iwanaga T; Saitoh K
J Pharm Pharmacol; 2016 Jan; 68(1):76-83. PubMed ID: 26589240
[TBL] [Abstract][Full Text] [Related]
27. Gout and uric acid nephropathy: some new aspects in diagnosis and treatment.
Löffler W; Simmonds HA; Gröbner W
Klin Wochenschr; 1983 Dec; 61(24):1233-9. PubMed ID: 6689351
[TBL] [Abstract][Full Text] [Related]
28. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor.
Krakoff IH; Murphy ML
Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486
[No Abstract] [Full Text] [Related]
29. Uricosuric effect of CGS-12970, a new thromboxane synthase inhibitor.
Saris SD; Piraino AJ; Morgan JM; Hirschhorn WL; Meidl E; Schaffer AV
Clin Pharmacol Ther; 1993 Jul; 54(1):65-9. PubMed ID: 8330466
[TBL] [Abstract][Full Text] [Related]
30. [Effects of xanthine oxidase inhibitor, 4-hydroxypyrazolo-(3, 4-d)-pyrimidine (zyloric) on the nucleic acid metabolism and its pharmacological actions. 1].
Isa M; Hayashi G; Kowa Y
Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):108-22. PubMed ID: 5749287
[No Abstract] [Full Text] [Related]
31. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
Mertz DP
Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
[No Abstract] [Full Text] [Related]
32. [Allopurinol in the treatment of hyperuricemia and chronic gout].
Benedetti A; Nardini A; Busonera G
Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
[No Abstract] [Full Text] [Related]
33. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
[TBL] [Abstract][Full Text] [Related]
34. Effects of probenecid and haemodialysis on human parotid fluid uric acid.
Shannon IL; Freeman RM
Arch Oral Biol; 1967 Feb; 12(2):291-6. PubMed ID: 5228192
[No Abstract] [Full Text] [Related]
35. [Danger of hyperuricemia in the treatment of acute leukemia, lymphosarcoma and reticulosarcoma].
Armata J
Pol Tyg Lek; 1974 Jun; 29(23):1005-6. PubMed ID: 4601064
[No Abstract] [Full Text] [Related]
36. Allopurinol treatment reduces arterial wave reflection in stroke survivors.
Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
Cardiovasc Ther; 2008; 26(4):247-52. PubMed ID: 19035875
[TBL] [Abstract][Full Text] [Related]
37. Influence of various purines on uric acid metabolism.
Zöllner N
Bibl Nutr Dieta; 1973; (19):34-43. PubMed ID: 4600927
[No Abstract] [Full Text] [Related]
38. The dual actions of morin (3,5,7,2',4'-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity.
Yu Z; Fong WP; Cheng CH
J Pharmacol Exp Ther; 2006 Jan; 316(1):169-75. PubMed ID: 16169936
[TBL] [Abstract][Full Text] [Related]
39. [Effect of colchicine and allopurinol on uricogenesis. I. Kinetics of their inhibitory action on hepatic xanthine dehydrogenase].
Escarmís C; Bozal J; Calvet F
Rev Esp Fisiol; 1970 Jun; 26(2):109-19. PubMed ID: 4324416
[No Abstract] [Full Text] [Related]
40. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
